Feed GSK
GS

GSK GSK NYSE · Healthcare · United Kingdom

$49.24 -2.32% -$1.17

Summary

62 / 100 · Bulios Score

What speaks for it

  • The share price is below the Bulios Fair Price.
  • Out of every 100 GBP of revenue, 13 GBP is left as net profit.

What to watch

  • Earnings per share fell by 28% a year over the last 3 years.
  • Earnings per share swing sharply from year to year.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $49.24

By our assumptions the business is worth more than its shares cost today.

P/E today 17.3 37% higher
5-year average P/E 12.6
P/E today 17.3
Drug Manufacturers - General industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 17.3 GBP for 1 GBP of yearly profit. Over the last five years it was 12.6 GBP on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (GBP)

Diluted EPS (GBP)

  • Analyst estimate

Revenue grew by 6.0% a year over 5 years. Over the last 3 years it grew by 3.7% a year. For the next fiscal year analysts expect revenue to grow by 4.9%.

Growth in detail

Does it make money?

Very well

Where 100 GBP of revenue goes

Net profit, industry median (Drug Manufacturers - General) 15 GBP

Out of every 100 GBP of revenue, 13 GBP is left as net profit.

Profitability in detail

Is it financially healthy?

Mostly

Repaying all its debt would take 3.5 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Moderate, stretched
Yield
3.74%
Paid out of profit
65%
Raised in a row
2 years

You receive $1.84 per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Neutral

Today's price within the analysts' price targets

The average target of $60 is 22% above today's price. 31% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2022

By product

By region

Sub Total brings in 100% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy